GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » GoodRx Holdings Inc (NAS:GDRX) » Definitions » EV-to-FCF

GoodRx Holdings (GoodRx Holdings) EV-to-FCF : 34.88 (As of Apr. 29, 2024)


View and export this data going back to 2020. Start your Free Trial

What is GoodRx Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, GoodRx Holdings's Enterprise Value is $2,878.8 Mil. GoodRx Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $82.5 Mil. Therefore, GoodRx Holdings's EV-to-FCF for today is 34.88.

The historical rank and industry rank for GoodRx Holdings's EV-to-FCF or its related term are showing as below:

GDRX' s EV-to-FCF Range Over the Past 10 Years
Min: 15.43   Med: 36.38   Max: 272.76
Current: 34.88

During the past 6 years, the highest EV-to-FCF of GoodRx Holdings was 272.76. The lowest was 15.43. And the median was 36.38.

GDRX's EV-to-FCF is ranked worse than
71.23% of 365 companies
in the Healthcare Providers & Services industry
Industry Median: 19.84 vs GDRX: 34.88

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-29), GoodRx Holdings's stock price is $7.15. GoodRx Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.020. Therefore, GoodRx Holdings's PE Ratio for today is At Loss.


GoodRx Holdings EV-to-FCF Historical Data

The historical data trend for GoodRx Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GoodRx Holdings EV-to-FCF Chart

GoodRx Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - 162.65 89.05 19.77 32.46

GoodRx Holdings Quarterly Data
Dec18 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.77 26.49 30.84 22.47 32.46

Competitive Comparison of GoodRx Holdings's EV-to-FCF

For the Health Information Services subindustry, GoodRx Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GoodRx Holdings's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, GoodRx Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where GoodRx Holdings's EV-to-FCF falls into.



GoodRx Holdings EV-to-FCF Calculation

GoodRx Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2878.805/82.526
=34.88

GoodRx Holdings's current Enterprise Value is $2,878.8 Mil.
GoodRx Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $82.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GoodRx Holdings  (NAS:GDRX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

GoodRx Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=7.15/-0.020
=At Loss

GoodRx Holdings's share price for today is $7.15.
GoodRx Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.020.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


GoodRx Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of GoodRx Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


GoodRx Holdings (GoodRx Holdings) Business Description

Traded in Other Exchanges
N/A
Address
2701 Olympic Boulevard, Santa Monica, CA, USA, 90404
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers other healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
Executives
Scott Wagner officer: Interim Chief Executive Office C/O WILSON SONSINI GOODRICH AND ROSATI, 650 PAGE MILL ROAD, PALO ALTO CA 94304
Raj Beri officer: Chief Operating Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Romin Nabiey officer: Chief Accounting Officer C/O GOODRX HOLDINGS, INC., 2701 OLYMPIC BOULEVARD, SANTA MONICA CA 90404
Andrew Slutsky officer: President & Consumer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Idea Men, Llc 10 percent owner 2701 OLYMPIC BOULEVARD, WEST BUILDING - SUITE 200, SANTA MONICA CA 90404
Karsten Voermann officer: Chief Financial Officer 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Trevor Bezdek director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Abdiel Qualified Master Fund Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Douglas Joseph Hirsch director, officer: Co-CEO 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Babak Azad officer: See Remarks 233 WILSHIRE ROAD, SANTA MONICA CA 90410
Bansi Nagji officer: President, Healthcare MCKESSON CORPORATION, 6555 STATE HIGHWAY 161, IRVING TX 75039
Agnes Rey-giraud director
Abdiel Capital Lp 10 percent owner C/O ABDIEL CAPITAL ADVISORS, LP, 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Advisors, Lp 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016
Abdiel Capital Management, Llc 10 percent owner 90 PARK AVENUE, 29TH FLOOR, NEW YORK NY 10016